04:43 PM EDT, 09/25/2025 (MT Newswires) -- Michael E Prevoznik, Senior Vice President & General Counsel, on September 23, 2025, sold 28,463 shares in Quest Diagnostics ( DGX ) for $5,326,042. Following the Form 4 filing with the SEC, Prevoznik has control over a total of 43,808 common shares of the company, with 38,117 shares held directly and 5,691 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1022079/000122267925000004/xslF345X05/wk-form4_1758832748.xml